Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

IL-6 antagonists from Daicel

Feb. 5, 1997

Dimethaid files second NDA for topical NSAID

Jan. 30, 1997

Dual COX-2/5-LO inhibitors reported by Searle

Jan. 29, 1997

Allelix develops antiinflammatory peptides

Jan. 29, 1997

COX-2 inhibitors reported by Merck Frosst

Jan. 28, 1997

Merck Frosst discovers orally active COX-2 inhibitors

Jan. 24, 1997

MMP inhibitors disclosed by Fuji Yakuhin

Jan. 24, 1997

Eisai discloses IL-1 inhibitors

Jan. 23, 1997

New COX-2 inhibitor series disclosed by Merck Frosst

Jan. 23, 1997

Novel antiinflammatory protein available for licensing

Jan. 22, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...